Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins-Reference-Cited by-同舟云学术

Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins

Published:2001-12 Issue:3 Volume:115 Page:672-678
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Tripodi Armando,Chantarangkul Veena,Clerici Marigrazia,Negri Barbara,Galli Monica,Mannucci Pier Mannuccio

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2001.03178.x/fullpdf

Reference16 articles.

1. Evaluation of a portable prothrombin time monitor for home use by patients who require long term oral anticoagulant therapy;Anderson;Archives of Internal Medicine,1993

2. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH;Brandt;Thrombosis and Haemostasis,1995

3. Silica clotting time (SCT) as a screening and confirmatory test for detection of the lupus anticoagulants;Chantarangkul;Thrombosis Research,1992

4. Potential failure of the international normalized ratio (INR) system in the monitoring of oral anticoagulation in patients with lupus anticoagulants;Della Valle;Annales de Medicine Interne,1996

5. Guidelines on the investigation and management of the antiphospholipid syndrome;Greaves;British Journal of Haematology,2000

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interference of lupus anticoagulant causing antiprothrombin and anti–beta-2-glycoprotein I antibodies on international normalized ratio measurements: comparative analysis of international normalized ratio methods;Research and Practice in Thrombosis and Haemostasis;2024-07

2. How the Hemostasis Laboratory can Help Clinicians to Manage Patients on Oral Anticoagulants;Mediterranean Journal of Hematology and Infectious Diseases;2024-02-29

3. Direct oral anticoagulants vs. vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis;Annals of Medicine & Surgery;2023-05-25

4. Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature;Seminars in Thrombosis and Hemostasis;2023-03-30

5. Interference in point-of-care international normalized ratio monitoring in patients with lupus anticoagulant is correlated with anti–β2-glycoprotein I antibody titers;Research and Practice in Thrombosis and Haemostasis;2023-01